Search

everythinglearnresearchcommunity

for

Search:↓

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

The research suggests that the ZP4 gene is linked to egg development in women with PCOS but requires more study to understand its role in infertility.

Eating less starch and dairy helped overweight women with PCOS lose weight and improve symptoms.

Increased HSD11B1 enzyme expression is linked to higher body fat and insulin resistance.

Five Weimaraners had a milder form of color dilution alopecia causing hair loss and skin issues.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

COVID-19 may harm male fertility and damage the reproductive system.

Non-coding RNAs help control hair growth in cashmere goats.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Testosterone replacement therapy should be used for men with low testosterone levels and symptoms of hypogonadism, after careful diagnosis and considering individual needs.

Researchers developed a nanomedicine for acne treatment that delivers medication with less irritation and is non-irritating for oily skin.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Micro-current stimulation may promote hair growth more effectively than standard treatments.

The document concludes that more research is needed to fully understand the causes of PCOS.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

Normal levels for certain hormones in Chinese women of reproductive age were identified.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Pranic meditation significantly improved mental health and quality of life for breast cancer survivors.

A yeast-based test can detect the steroid methyltestosterone in urine longer than traditional methods.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

Progesterone and its byproducts control a specific receptor in the brain independently of progesterone receptors, affecting conditions related to the menstrual cycle.